• Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Apr 30, 2019
Distillery Therapeutics

RUNX1, RUNX3, CBFB and PMP22 as targets for neurofibromatosis

Read More
BioCentury | Apr 16, 2015
Distillery Therapeutics

Therapeutics: Histone deacetylase (HDAC); runt-related transcription factor 3 (RUNX3)

Read More
Items per page:
1 - 2 of 2
Help Center
Username
Request Training
Submit Data Correction
Ask a Question
Elevio by Dixa